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Mesangiolytic glomerulopathy in severe congestive heart failure. To
study the glomerular morphological abnormalities in congestive heart
failure (CHF), we analyzed 27 autopsy cases without other causes of renal
disease. Their mean age was 59 years, and they showed mild prerenal
azotemia. They had generally been treated with digitalis and diuretics, and
a few of them with captopril or nifedipine. The abnormal glomerular
findings of enlargement, hyperemia, and mesangial thickening were
observed at high frequencies (61%, 64%, and 57%, respectively). They
characteristically showed mesangiolysis (ML) by the findings of microan-
eurysms (81%) and mesangial degeneration (70%) such as loose reticular
matrix and poor matrix area. In addition, glomerular infiltration of
mononuclear leukocytes including macrophages was noted in 70% of the
cases. Glomerular enlargement was not correlated with the grade of
hyperemia, but it was correlated with the grade of ML index of %
glomeruli with microaneurysms (F 5 7.22, p , 0.004). There was an
inverse relationship between the grades of mesangial thickening and of the
ML index (P , 0.005). The number of glomerular leukocytes was
positively correlated with mean glomerular size (P , 0.002) and with the
ML index (P , 0.03). Notably, the glomerular macrophage-positive cases
showed a prominently higher mean ML index than the negative cases (P ,
0.005). There was an inverse correlation between the mean glomerular
size and the partial oxygen pressure in arterial blood (PaO2; P , 0.01), and
a positive correlation between the mean glomerular size and hematocrit
(Hct) levels (P , 0.02). The cases positive for mesangiolytic mesangial
degeneration showed significantly lower PaO2 values than the cases
negative for this lesion (P , 0.04). In the analysis of the various causes of
CHF, the patients with congenital cardiac anomalies showed mean levels
of the lowest PaO2 (P , 0.02) and the highest Hct (P , 0.03) and
histologically the largest mean glomerular size (P , 0.04). There was no
difference in the ML index and the glomerular leukocyte number among
the subgroups classified by the causes. These results indicate that ML
associated with glomerular enlargement is the major glomerular abnor-
mality characteristic in patients with severe CHF and suggest that
glomerular infiltration of leukocytes, especially of macrophages, should
play an important role in the progression of both ML and glomerulo-
megaly. The contributions of persistent hypoxia and up-regulated angio-
tensin II as the causative factors of these glomerular abnormalities in
congestive heart failure are discussed.
In patients with congestive heart failure (CHF), inadequate
cardiac output decreases renal plasma flow and the neurohor-
monal mechanisms of the renin-angiotensin-aldosterone system,
sympathetic nervous system and vasopressin contribute to in-
creased tubular reabsorption of sodium and water, leading to
edema [1, 2]. Experimental studies of the glomerular hemody-
namic effect of angiotensin II suggest that increased circulating
and locally produced angiotensin II causes renal vasoconstriction,
particularly of the glomerular efferent arterioles, and conse-
quently marked elevation of filtration fraction as CHF becomes
more severe [3, 4]. In addition, recent studies suggest that
angiotensin II not only causes glomerular ischemia or glomerular
hyperfiltration, but also glomerular matrix accumulation that
finally leads to nephrosclerosis [5, 6].
Although slight or mild proteinuria is often observed in patients
with CHF with rare development of nephrotic syndrome [7–9],
there have been few morphological studies on the glomerular
changes in patients with CHF. In previous reports, “dilation of
glomerular space” [10] and the presence of globally sclerosed
glomeruli [11] are described as the major findings accompanying
arteriolar sclerosis related to hypertension. It has been shown that
in patients with cyanotic congenital heart disease, of those where
CHF is often accompanied as a major manifestation, prominent
glomerulomegaly is frequently observed with hypercellularity of
the glomerular tuft, glomerular congestion and elongation of the
capillary loop [12–15]. In this disease and chronic cor pulmonale,
chronic hypoxia and polycytemia are considered to be causative
factors in the pathogenesis of glomerulomegaly, as shown by the
quantitative correlation between hematocrit level and the glomer-
ular size [14]. Because the patients with severe CHF generally
exhibit different degrees of hypoxemia, we analyzed the glomer-
ular changes with a particular emphasis on CHF’s relationship
with chronic hypoxia. We examined the glomerular abnormalities
in patients diagnosed with severe CHF but neither coexisting primary
glomerular diseases nor systemic diseases causing glomerulopathy,
such as diabetes mellitus and infective endocarditis. The results
revealed that the characteristic glomerular findings in severe CHF
are mesangiolysis and glomerular enlargement associated with en-
docapillary leukocytic infiltration. The pathogenetic role of persistent
hypoxia and increased angiotensin II activity is discussed.
METHODS
Patients
In total, 27 patients (18 male and 9 female patients) who died
of chronic CHF between 1984 and 1990, at Kyoto University
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Hospital or Amagasaki Hospital were studied. Patients bearing
any primary renal disease or systemic disease known to complicate
renal manifestations, such as membranous nephropathy (1 case),
diabetes mellitus (2 cases), infective endocarditis (1 case) and
candidiasis with kidney involvement (1 case) were excluded from
this study. The patients with diabetes mellitus were ruled out by
the clinical history and blood examination of glucose level. The
mean age was 59 6 16 years old and the mean duration of heart
failure was 6.7 years (range, 0.2 to 20 years). Heart failure was
both right and left sided in 18 cases and left sided in 9 cases. Two
cases had cor pulmonale, case No. 16 with old myocardial
infarction and emphysema and case No. 17 with pulmonary
hypertension. Ten cases had a prior history of hypertension.
The diseases that generated CHF were old myocardial infarc-
tion (OMI) in ten cases, valvular heart diseases (VD) in seven
cases, cardiomyopathy (CM) in five cases, congenital cardiac
anomalies (CA) in three cases, pericarditis in one case and
pulmonary hypertension in one case. The rheumatic origin was
confirmed in case No. 3 with mitral and aortic valvular disease,
and was suspected in all of the remaining cases categorized in
valvular disease and in 1 case grouped in the congenital anomaly
(case No. 18). The details of these causes are shown in Table 1.
Blood pressure was measured at the brachial artery with a
standard mercury sphygmomanometer when the patient was in a
supine position at a resting condition. The mean values for blood
pressure and the mean arterial pressure (MAP) were 116 6
17/67 6 14 mm Hg and 83 6 13 mm Hg, respectively. The data on
partial oxygen pressure in arterial blood (PaO2) were available in
21 cases and hypoxemia defined with aging factor [16] was evident
in all cases, exhibiting the mean PaO2 of 62.0 6 12.1 mm Hg. The
mean hematocrit (Hct) was 36.8 6 7.9% and ranged from 24.6
to 63.6%. Proteinuria tested by paper strip method was graded 0
(2 to 6) in 7, 1 (1) in 10, and 2 (11 to 111) in 7 patients. The
mean levels of serum creatinine (SCr) and BUN were 1.46 6 0.37
mg/dl and 36.6 6 12.3 mg/dl, respectively. The data of cardiac
output by cardiac catheterization or left ventricular ejection
fraction by echocardiography were available in 15 patients and all
of them showed depressed cardiac function. The clinical data for
each patient are summarized in Tables 2 and 3.
Most patients had been orally treated with digitalis (83%),
diuretics such as furosemide and spironolactone (83%), and
various vasodilators (78%; nitrates in 8 patients, nifedipine in 4,
diltiazem and prazosin each in 2, and captopril and metoprolol in
1 each). In addition, anti-platelet drugs (30%) and anti-coagulants
(26%) had been orally administered. Catecholamines (39%) had
been intravenously administered in patients who were critically ill
or in a shock condition. For seven patients who had complications
with acute renal failure, at the time of death the clinical data used
were those obtained before the onset of the renal failure. At
autopsy, the mean cardiac weight and single kidney weight were
599 6 194 g (range 345 to 1,050 g) and 150 6 32 g (95 to 202 g),
respectively. Heart failure cells in the lung were observed in 22
cases, and fibrosis of the alveolar septum in 22. In the liver, central
necrosis and thickened central vein were observed in 24 and 22
cases, respectively. As controls, 15 age-matched autopsy cases
with neither CHF nor renal diseases were studied. The causes of
death were cancers of the digestive system in 6 of these cases,
neurological diseases in 4, hematological malignancies in 2,
pharyngeal cancer in 2, and inflammatory bowel disease in 1.
Morphology
Kidney sections were stained by hematoxyline-eosin, periodic
acid Schiff (PAS), and silver methenamine methods (PAM). The
glomerular size was measured as the whole capillary tuft area by
a computed image analyzer (Pias System, Japan) for 50 glomeruli
other than obsolescent glomeruli on each slide by serpentine
scanning under light microscopy. The average glomerular size was
calculated for each patient. Mesangiolysis (ML) was evaluated by
the presence of (1) capillary microaneurysm with disrupted an-
choring point, (2) mesangial degeneration of a poor matrix area
and loose reticular matrix staining, and (3) in the severe form,
segmental necrosis [17]. The ML index was expressed as the
percentage of glomeruli exhibiting characteristic microaneurysmal
formation after counting of 100 glomeruli per slide. In the CHF
cases, the ML index values less than 2 SD above the mean for the
controls (that is, 47% or less) were regarded as negative (grade 0)
and the values from 48 to 90% and those 91% or greater were
categorized as grade 1 and grade 2, respectively. Endocapillary
mononuclear leukocyte infiltration was recorded as the average
number of leukocytes per glomerulus after counting 25 glomeruli
in each case. The extent of glomerular hyperemia, mesangial
thickening and glomerular obsolescence was graded as 0 (negative
to slight), 1 (mild), and 2 (moderate to severe). Microscopic
findings were evaluated by three renal pathologists who were
blinded to any information on clinical data.
Immunohistochemistry of macrophages
Immunoenzyme indirect staining was performed on formalin-
fixed paraffin-embedded tissue by a method described previously
[18]. The first antibody was reacted to detect CD68 macrophage-
related antigen (KP-1 monoclonal antibody; DAKO Co. Ltd,
Tokyo, Japan). The substrate solution was reacted for color
development after the incubation with the second antibody la-
beled with horseradish peroxidase. A total of 8 slides showing
various degrees of positivity for interstitial cells were selected for
evaluation and assessed for antigenicity.
Table 1. Diseases that cause congestive heart failure (CHF)
Category Disease
No. of
cases
1. Congenital anomaly ASD 1
ASD, mitral stenosis, and TR 1
Single atrium, single ventricle,
pulmonic stenosis and TAPVC
1
2. Old myocardial
infarction
10
3. Valvular disease Aortic regurgitation 2
Aortic stenosis 2
Mitral stenosis 1
MSR and aortic regurgitation 1
MSR, aortic regurgitation and TR 1
4. Cardiomyopathy Dilated cardiomyopathy 3
Hypertrophic cardiomyopathy 1
Post-myocarditis 1
5. Others Pericarditis 1
Pulmonary hypertension 1
Abbreviations are: ASD, atrial septal defect; TR, tricuspid regurgita-
tion; TAPVC, total anomalous pulmonary venous connection; MSR,
mitral stenosis and regurgitation.
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Statistics
Results are expressed as the mean 6 SD. The unpaired t-test,
simple regression test and one way analysis of variance were
employed for statistical analysis. P values less than 0.05 obtained
by two-tailed method were regarded as significant.
RESULTS
Microscopic findings
The number of large glomeruli (2.5 to 4.0 3 1022mm2) was
generally increased in the CHF cases compared to the controls.
Figure 1 shows frequency distributions of glomerular size for a
control and for a CHF case (Case No. 1). The mean value of the
average glomerular size in the CHF cases (2.21 6 0.38 3
1022mm2) was significantly (P 5 0.0002) greater than that in the
controls (1.72 6 0.31 3 1022mm2; Fig. 2A). The ML index, based
on the percentage of microaneurysmal glomeruli, was significantly
(P 5 0.0001) higher in CHF patients (73.0 6 24.5%) than that in
the controls (34.4 6 6.0%; Fig. 2B). The ML index was graded 0,
1 and 2 in 5, 15 and 7 of the CHF cases, respectively. Glomeruli
with mesangiolytic mesangial degeneration were observed in 19
cases (70%) in CHF patients, whereas the controls showed no
apparent lesion. It was noted that all of the glomeruli positive for
mesangiolytic mesangial degeneration were accompanied with
microaneurysmal lesions. Segmental lobular necrosis was ob-
served with microaneurysmal and mesangial degenerative lesions
in cases No. 21 and 22.
The mean number of endocapillary mononuclear leukocytes in
CHF cases (10.9 6 3.5) was significantly (P 5 0.0003) higher than
that in the control group (5.7 6 1.7), and 70% of the CHF cases
showed the number more than 2 SD above the mean for the
controls (Fig. 2C). Among the mononuclear leukocytes, macro-
phage-like cells with abundant cytoplasm, often bearing hemosid-
erin granules, were noted in 19 cases (70%), but the proportion of
polymorphonuclear leukocytes was low. Glomerular hyperemia
with engorged capillaries was noted in 17 cases (grade 1 in 9 and
grade 2 in 8). The mesangial thickening was generally slight to
mild (grade 0 in 12, grade 1 in 13, and grade 2 in 2). The
glomerular obsolescence, graded by the number of glomeruli with
complete obsolescence was grade 0 (slight) in 11 cases, grade 1
(mild) in 12 and grade 2 (moderate) in 4. Except for the
completely obsolescent glomeruli, there was no glomerulus with
advanced sclerosis exceeding moderate mesangial thickening. As
for vascular lesions, arterial sclerosis was noted in cases No. 20
and 22, and severe arteriolar sclerosis was in case No. 16. Renal
infarction was observed in cases No. 3 and No. 27. The micro-
scopic glomerular findings are summarized in Table 4, and the
representative photographs are shown in Figure 3.
Immunohistochemistry
Of the 8 slides subjected to the CD68 study, 6 showed endo-
capillary cells positive for CD68 [grade 1 (mild) in 3, grade 2
(moderate) in 1 and grade 3 (severe) in 2]. These endocapillary
CD68-positive cells corresponded to macrophage-like leukocytes
with extensive cytoplasm revealed by PAS staining (Fig. 4).
Table 2. Clinical profiles of the patients with congestive heart failure (CHF)
No Sex
Age
years Causes
Duration
years
Right or
left sided
Cor
pulmonale
History of
hypertension
1 M 62 OMI 0.8 R & L 2 1
2 M 67 OMI 12 R & L 2 1
3 F 55 aMSR,AR 10 R & L 2 2
4 F 56 aAR 3 R & L 2 2
5 M 64 PC 9 R & L 2 2
6 M 57 aMSR,AR,TR 12 R & L 2 2
7 M 73 OMI 5 R & L 2 1
8 M 76 OMI 11 R & L 2 2
9 M 65 OMI 3 L 2 2
10 M 66 OMI 12 R & L 2 1
11 M 23 PMD 1 R & L 2 2
12 M 54 DCM 2 L 2 1
13 M 69 OMI 20 L 2 1
14 M 64 ASD 4 R & L 2 2
15 F 12 DCM 0.3 L 2 2
16 M 65 OMI 0.5 R & L 1 1
17 M 56 PH 5 R & L 1 2
18 F 52 aASD,MS,TR 14 R & L 2 2
19 M 55 aAR 1 L 2 2
20 M 68 OMI 9 L 2 1
21 F 28 SA,SV,PS,TAPVC 0.3 R & L 2 2
22 M 77 OMI 4 L 2 1
23 F 62 aAS 8 R & L 2 2
24 F 77 aAS 7 L 2 2
25 F 80 aMS 11 L 2 1
26 M 41 DCM 17 R & L 2 2
27 F 55 HCM 0.2 R & L 2 2
Abbreviations are: M, male; F, female; OMI, old myocardial infarction; MSR, mitral stenosis and regurgitation; AR, aortic regurgitation; PC,
pericarditis; TR, tricuspid regurgitation; PMD, post-myocarditis; DCM, dilated cardiomyopathy; ASD, atrial septal defect; PH, pulmonary hypertension;
MS, mitral stenosis; SA, single atrium; SV, single ventricle; PS, pulmonic stenosis; TAPVC, total anomalous pulmonary venous connection; AS, aortic
stenosis; HCM, hypertrophic cardiomyopathy; R & L, right and left sided heart failure; L, left sided heart failure.
a Possibility of rheumatic heart disease
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Correlations among clinical parameters
Patients with a history of hypertension showed significantly
increased MAP and SCr levels than those without a history (for
MAP, 90.6 6 11.3 vs. 79.1 6 11.3 mm Hg, P , 0.02; and for SCr,
1.7 6 0.4 vs. 1.4 6 0.3 mg/dl, P , 0.05). The patients with both
right and left sided CHF showed significantly lower MAP than
those with left sided CHF (79.8 6 11.4 vs. 90.6 6 11.8 mm Hg, P ,
0.04), which was attributed to the difference of systolic pressures
(109.8 6 13.5 vs. 127.0 6 17.0 mm Hg, P , 0.01). Neither
hypertensive history nor right and left sided condition was corre-
lated with the other clinical and histological parameters. There
were positive correlations between age and MAP (P , 0.04) and
between MAP and SCr levels (P , 0.02; Fig. 5 A,B), but there was
no significant correlation between the age and SCr levels (data not
shown). An inverse significant correlation was observed between
PaO2 and Hct levels (P , 0.01; Fig. 5C). A case with pulmonary
hypertension (No. 17) exhibiting cor pulmonale and low PaO2
(42.0 mm Hg) showed the highest Hct (63.6%) of these patients.
The grades of proteinuria and blood urea nitrogen (BUN) levels
were not correlated with any other clinical parameters. Notably,
BUN levels tended to be disproportionately high in comparison
with SCr, which showed a range of primarily mild increases (Fig.
5D). A comparison among the various causes of CHF found that
the patients with CA showed significantly lower PaO2 (P , 0.02)
and higher Hct levels (P , 0.03) than those with other causes
(Fig. 6).
Correlations among glomerular histological findings
The mean glomerular size was not correlated with the extent of
glomerular hyperemia. When ML was evaluated by % glomeruli
with microaneurysmal lesion, the extent of ML showed a slight but
not significant association with the mean glomerular size. How-
ever, the cases with higher ML grades showed significantly larger
mean glomerular size (P , 0.004): 1.85 6 0.36 31022mm2 in
grade 0, 2.18 6 0.29 31022mm2 in grade 1 and 2.55 6 0.32
31022mm2 in grade 2 (Fig. 7). The cases with higher grades of
mesangial thickening exhibited lower percentage ML: 88.0 6
14.7% in grade 0, 64.9 6 23.6% in grade 1 and 40.0 6 28.3% in
grade 2 (P 5 0.004). The mean number of glomerular leukocytes
was positively correlated with the mean glomerular size and ML
index (P , 0.002 and P , 0.03, respectively; Fig. 8). In addition,
patients (19 cases) positive for endocapillary macrophage-like
leukocytes showed significantly higher mean ML index (82.1 6
20.2%) in comparison with those (8 cases) without these cells
(51.3 6 28.2%; P , 0.005).
With regards to the presence of mesangiolytic mesangial de-
generation, the patients positive for this finding showed signifi-
cantly higher levels of both ML index and mean number of
glomerular leukocytes than those negative for this finding (for ML
index; 85.4 6 13.9 vs. 47.9 6 28.5%, P 5 0.0001 and for the
leukocyte number; 11.0 6 2.9 vs. 8.9 6 3.8, P , 0.03). Similarly,
the patients with the mesangial degeneration showed a larger
mean glomerular size (2.32 6 0.37 31022mm2) than those
without this finding (2.01 6 0.35 31022mm2), although the
statistical difference was slight (P 5 0.051).
Relationship between clinical and histological data
All of the five patients less than 53 years old showed grade 0
glomerular obsolescence. On the other hand, the older patients
Table 3. Clinical tests of the patients with congestive heart failure
(CHF)
Patient
no.
PaO2
mm Hg
Hct
%
MAP
mm Hg
Proteinuria
(grades 0, 1, 2)
SCr BUN
mg/dl
1 66.5 42.8 88 1 1.6 29
2 76.8 37.8 72 1 1.3 45
3 69.0 31.3 94 2 1.0 52
4 70.9 32.5 59 2 1.1 50
5 80.0 27.2 85 1 1.6 59
6 NA 36.0 81 1 1.6 20
7 67.0 36.0 85 0 1.3 23
8 60.0 30.3 68 0 1.0 19
9 52.0 34.4 92 0 1.7 21
10 57.0 35.4 72 NA 1.7 44
11 58.0 36.7 77 1 1.3 36
12 NA 34.0 97 NA 2.2 52
13 NA 42.8 93 NA NA 15
14 46.3 42.4 77 1 1.2 37
15 53.1 39.7 67 1 0.9 29
16 65.8 32.9 101 0 1.3 58
17 42.0 63.6 80 0 2.2 40
18 34.5 36.8 90 2 1.0 39
19 74.4 27.8 93 2 1.5 37
20 NA 32.5 103 1 1.6 22
21 56.8 52.5 61 2 1.2 33
22 56.5 40.7 100 2 1.7 20
23 NA 35.2 78 2 1.4 38
24 68.5 24.6 75 0 1.2 20
25 NA 40.2 95 0 2.2 41
26 79.0 30.3 73 1 1.4 41
27 68.4 37.6 95 1 1.7 46
Abbreviations are: PaO2, partial oxygen pressure in arterial blood; Hct,
hematocrit; MAP, mean arterial pressure; proteinuria, graded 0 to 2 by
paper strip (0, 2 to 6; 1, 1; 2, 11 to 111); SCr, serum creatinine; NA,
data not available.
Fig. 1. Comparison of glomerular size in a case of congestive heart
failure (CHF; Case 1) and a control. Glomerular size is expressed as the
area encircled by the peripheral border of the glomerular tuft, which was
measured for 50 glomeruli in each subject under microscopy with a
computed image analyzer. The frequency of glomeruli larger than 2.5 3
1022mm2 was increased in the case, showing larger mean size (2.29 3
1022mm2) than that of the control (1.48 3 1022mm2). Symbols are: (o)
control; (3) case 1, CHF.
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showed significantly (P , 0.02) wider range of scores (grades 0, 1
and 2 in 6, 12, and 4 cases, respectively). There was no significant
difference between the age groups for any other histological
findings examined. The MAP level was significantly correlated
with the obsolescence score, showing the highest mean MAP in
grade 2 patients (P , 0.02), but MAP was not correlated with
other morphological findings.
Quantitatively, PaO2 levels showed an inverse correlation with
the mean glomerular size (P , 0.01); on the one hand, Hct levels
showed a positive correlation with the glomerular size (P , 0.02)
(Fig. 9). There was no significant quantitative correlation of ML
index with PaO2 nor with Hct. On the other hand, in comparison
of the positivity of the mesangiolytic mesangial degeneration, the
subgroup of 14 patients with this finding showed significantly
Fig. 2. Comparison of the mean values for the average glomerular size (A), glomerular mesangiolysis (ML) (B) and number of glomerular
mononuclear leukocytes (C) between 15 controls and 27 congestive heart failure (CHF) cases. The CHF cases showed significantly higher values in each
comparison. The data are mean 1 SD. In (A) P 5 0.0002; in (B), P 5 0.0001; in (C) P 5 0.0003.
Table 4. Glomerular morphological data in patients with congestive heart failure (CHF)
No. Hyperemiaa
Sizeb
(3 102mm2)
Mesangiolysis Mesangial
thickeninga
No. of
leukocytesb
Glom.
Obs.a%c Deg.d
1 2 2.29 83 1 1 12.3 0
2 2 2.13 70 2 0 12.2 1
3 0 1.90 20 2 1 6.3 2
4 0 1.91 82 1 1 9.6 0
5 0 1.41 43 2 1 5.8 1
6 0 1.85 2 2 2 6.2 1
7 2 2.52 82 1 1 13.2 1
8 1 1.68 42 2 1 4.0 1
9 2 2.50 73 1 0 10.7 0
10 1 1.78 84 1 0 11.5 0
11 2 2.24 77 2 1 13.2 0
12 1 2.21 57 1 0 12.9 2
13 0 2.39 28 2 1 14.2 0
14 0 2.73 58 1 1 16.8 1
15 2 1.88 82 1 0 11.6 0
16 1 2.50 60 2 2 11.4 2
17 1 2.38 70 1 1 6.6 1
18 2 2.77 93 1 0 7.8 0
19 2 2.19 100 1 0 14.1 0
20 0 1.84 90 1 1 11.0 2
21 0 2.73 100 11 0 12.4 0
22 0 2.85 98 11 0 12.3 1
23 1 2.74 100 1 0 17.3 1
24 0 2.03 99 1 0 14.1 1
25 1 2.49 100 1 0 13.5 1
26 1 1.98 89 2 1 6.9 0
27 1 1.81 87 1 1 7.3 1
Abbreviation is: Glom. Obs, glomerular obsolescence.
a Graded from 0 to 2 (0, negative to slight; 1, mild; 2, moderate to severe)
b Mean value obtained by counting 50 and 25 glomeruli, respectively
c % glomeruli with microaneurysm by counting 100 glomeruli.
d mesangial degeneration (poor matrix or loose reticular staining): 2, negative only with microaneurysm; 1, positive; 11, positive with segmental
necrosis
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lower mean PaO2 levels than the subgroup of 7 patients without
this finding (58.1 6 11.8 vs. 69.8 6 11.8 mm Hg, P , 0.04).
However, there was no significant correlation of the mesangial
degeneration with Hct, nor with other clinical parameters.
With regards to the causes of CHF, the cases with CA showed
significantly (P , 0.04) larger mean glomerular size (2.75 6 0.02
31022mm2) than did those with OMI (2.25 6 0.38 31022mm2),
VD (2.16 6 0.34 31022mm2) and CM (2.05 6 0.19 31022mm2;
Fig. 10A). In comparison with the controls, the patients with CA,
OMI and VD showed significantly increased mean glomerular size
(P , 0.0001, P , 0.001 and P , 0.01, respectively), whereas the
patients with CM did not show a significant difference from the
controls. The ML index and glomerular leukocyte number did not
differ among the subgroups (Fig. 10 B,C). The patients with
valvular diseases, with a probability of rheumatic disease, did not
show a significant difference of glomerular findings compared
with those without valvular disease. None of the grades of
proteinuria and SCr and BUN levels was significantly correlated
with any histological findings.
DISCUSSION
In the present study, we found that mesangiolysis (ML) and
glomerular enlargement associated with mononuclear leukocyte
infiltration are the characteristic glomerular abnormalities in
patients with severe congestive heart failure (CHF). Mesangioly-
sis has been described in various conditions such as Habu snake
poisoning [17, 19], hemolytic uremic syndrome [20], diabetic
nephropathy [21–23], Takatsuki’s syndrome [24] and in focal
segmental glomerulosclerosis associated with infantile spasms
[25]. Microscopically, ML has been documented by the presence
of disrupted anchoring points of the capillary wall with microan-
eurysmal dilation, mesangial degeneration of poor matrix area or
loose reticular appearance of mesangial matrix on PAS staining,
and in severe cases, accompanied with segmental mesangial
necrosis [17, 19–25]. To semiquantitatively compare ML with
other findings, we used the ML index based on the percentage of
glomeruli with the microaneurysmal lesions, together with the
qualitative evaluation of ML by the mesangial degeneration. In
Fig. 3. Characteristic microscopic findings for glomeruli in congestive heart failure (CHF) patients (A–G, PAS staining; and H, PAM staining; original
magnification, A–F and H 3100, and G, 3400). (A) A glomerulus with moderate mesangial thickening without mesangiolysis (Case 6). (B) Prominent
microaneurysmal dilation of hyperemic capillaries with endocapillary leukocyte infiltration (Case 11). (C) Capillary wall thickening with endothelial
swelling and poor staining of mesangial matrix (Case 4). (D) Mononuclear leukocyte infiltration and hyperemia in microaneurysmal glomerular
capillaries (Case 2). (E) Reticular staining of moderately thickened mesangium and endocapillary mononuclear leukocyte infiltration in an enlarged
glomerulus (Case 16). (F) Case 19 and (G) Case 10, severe ML exhibiting prominent microaneurysm formation and poor matrix staining. Mononuclear
leukocytes with macrophage-like appearance are noted in the capillaries. (H) A glomerulus exhibiting segmental necrosis of advanced ML (Case 21).
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contrast to a significantly higher mean ML index (73.0 6 24.5%)
in the CHF cases, the low, but not negligible, index (34.4 6 6.0%)
was obtained in the controls. With this regard, various cytotoxic
conditions before the death such as cahexia, hypoxia, malnutri-
tion, circulatory disturbance, or prolonged use of anti-cancer
drugs should be considered as the possible causes of microaneu-
rysmal formation in the controls, since diseases capable of caus-
ing ML such as diabetes mellitus and vascular diseases were
excluded. The findings that the control patients did not show
mesangiolytic mesangial degeneration, which was frequently ob-
served in the CHF cases (70%), suggest that in the control
patients, the mesangiolytic lesion may be confined within anchor-
ing points without further progression to global mesangial degen-
eration because mesangiolytic changes proceed from capillary
Fig. 3. Continued.
Fig. 4. Comparison between endocapillary infiltrating cells stained by PAS (A) and anti-CD68 immunostaining for macrophages (B) in a glomerulus
in Case 10. The infiltrating mononuclear cells with abundant cytoplasm in (A) coincide with the anti-CD68-positive cells (stained red in B).
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endothelium to mesangium. The correlation found in this study
between the mean glomerular size and ML index and the inverse
relationship between ML index and the grade of mesangial
thickening, suggest that mesangial thickening may be replaced by
mesangiolytic changes producing increased glomerular size as the
disease progresses.
As discussed in previous reports [13, 14, 26, 27], the predomi-
nant glomerulomegaly in patients with congenital cyanotic heart
disease may be related to severe prolonged hypoxia. Bauer and
Rosenberg have described quantitative correlation of glomerular
area with red blood cell counts and with hemoglobin values in 29
children with tetralogy of Fallot [14]. In contrast, we analyzed
elderly patients with CHF including only three cases having
congenital heart disease; however, the data that all of the CHF
cases examined were hypoxemic should make the present study
comparable to the former studies on cyanotic congenital heart
disease. The significant inverse relationship between PaO2 and
Hct levels in this study suggests that hypoxia might have stimu-
lated erythrocyte production in cases with CHF. Further, we
disclosed that both extent of hypoxemia and the Hct levels were
significantly correlated with the extent of glomerulomegaly. A
relevant finding was obtained in the comparison of causes of CHF:
The patients with CA having the lowest mean PaO2 and the
highest mean Hct levels, showed more prominent glomerulo-
megaly than did those with other acquired causes of CHF (OMI,
VD and CM). The hypoxic effect in the development of glomeru-
lomegaly has also been suggested in recent experiments. In
cultured rat mesangial cells, hypoxia stimulated synthesis of
extracellular matrix of type IV collagen and fibronectin [28]. In
addition, hypoxia stimulates not only erythropoietin production in
interstitial fibroblasts, but also modulates endothelial cell proper-
ties and induces expression of growth factors such as endothelin-1,
interleukin-6, platelet-derived growth factor and vascular endo-
thelial growth factor [29, 30]. In one recent study, the glomerular
volume in CHF was not significantly increased in comparison with
that in controls [26]. However, the direct comparison with our
present data seems to be inappropriate, because the histological
findings for glomeruli and the history of treatment are not
described in the reported study. Their description that 6 of 8 cases
examined had cardiomyopathy and they were not severely hy-
poxic, is consistent with our data; our patients with cardiomyop-
athy did not show significantly larger glomeruli than controls,
whereas our patients with CA, OMI and VD showed significantly
increased mean glomerular size.
Fig. 5. Comparison among the clinical parameters in congestive heart failure (CHF) patients. There were significant quantitative relationships
between mean arterial pressure (MAP) and age in years (r 5 0.4, P , 0.04, A) and between serum creatinine (SCr) level and MAP (r 5 0.465, P , 0.02,
B). There was a significant inverse correlation between PaO2 and hematocrit (Hct) (r 5 0.579, P , 0.01, C). There was no significant correlation between
SCr and BUN, with relatively higher BUN levels than SCr (r 5 0.114, P 5 NS. D).
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The ML index expressed by % glomeruli with microaneurysm
was not correlated with PaO2 level, however, the CHF cases
positive for mesangiolytic mesangial degeneration showed signif-
icantly lower PaO2 levels than those without this finding (P ,
0.04). There was no significant association between Hct and
ML qualified by either the ML index or mesangial degenera-
tion. These findings seem to suggest that not Hct but hypox-
emia may play a role rather in the advancement of ML, than in
the early development of ML. Electron microscopic data may
be helpful to clarify more subtle changes in the progression of
ML [19, 20].
In addition to its glomerular hemodynamic effects, angiotensin
II has been implicated in glomerular cell hypertrophy and sclero-
sis [5, 6]. Molecular studies recently clarified that angiotensin II
locally stimulates glomerular mesangial cells to produce and
activate transforming growth factor-b (TGF-b), which increases
production of extracellular matrix components such as biglycan,
collagen type I and fibronectin [31]. Therefore, the glomerulo-
megaly and mild-to-moderate mesangial thickening seen in our
patients may, at least partly, be attributed to stimulated angioten-
sin II activity. It seems likely that the combined effect of hypoxia
and glomerular hyperfiltration, related to up-regulated angioten-
sin II, induced glomerular endothelial perturbation, which subse-
quently led to mononuclear cell infiltration through the expres-
sion of adhesion molecules or proinflammatory cytokines. Indeed,
it has been shown that tetrapeptides of angiotensin II preferen-
tially stimulated chemotaxis of human mononuclear leukocytes in
an in vitro experiment [32], and that angiotensin II enhanced
phagocytosis of macrophages through binding to angiotensin II
receptors on the cells in a murine model of inflammation [33]. The
infiltration of mononuclear cells in microaneurysms of mesangio-
lytic glomeruli has been described in a few reports [19, 23], but
this is not so clearly mentioned as to suggest the major pathogenic
role of mononuclear cells in the development of ML. In the
present study, the mean number of infiltrating mononuclear
leukocytes was significantly correlated with ML (both microaneu-
rysm and mesangial degeneration) and with the mean glomerular
size. Such infiltrating mononuclear leukocytes, which include
macrophages as the major population as shown by CD68 staining,
should have accelerated mesangiolytic changes causing glomeru-
lar enlargement, probably by releasing proteolytic enzymes, free
radicals and nitric oxide [34, 35].
Although the presence of glomerular obsolescence in these
patients may suggest the possible role of decreased arterial
perfusion or concomitant development of benign nephrosclerosis,
the characteristic finding of ML with glomerular enlargement
cannot be attributed to ischemic glomerulopathy, nor to nephro-
sclerosis caused by hypertension [36], because renal artery steno-
sis, which is a major cause of ischemic nephropathy, was not
evident, and because hypertension was not a common feature;
rather, their MAP was low to normal, reflecting the lethal nature
of the CHF. We examined the past history of hypertension, which
might be attenuated in heart failure, but it was not correlated
with any mesangiolytic findings nor with glomerulomegaly. On
the other hand, the MAP level was significantly correlated with
the grade of glomerular obsolescence. These findings suggest
that glomerular obsolescence may be attributed to associated
hypertension, in addition to the aging factor. The patients in
this study were generally treated with diuretics and digitalis, in
combination with various vasodilators such as nitrates and
nifedipine. However, the use of angiotensin converting enzyme
inhibitors (ACEI), long-acting calcium antagonists and
b-blockers, currently used in the treatment of CHF, was
exceptional in these patients [37]. The severe ML in these
patients may have been related to the nature of the treatment
of CHF. Since it has been well described that ACEI amelio-
rates not only glomerular hypertension, but also the progres-
sion of glomerulosclerosis in both experimentally-induced and
clinical renal diseases [38 – 41], it is highly probable that their
glomerular abnormalities might have been less severe had they
been treated with ACEI [42]. In this context, we recently
conducted a clinical study of glomerular hyperfiltration and
sclerosis in outpatients with CHF where we found that patients
treated with ACEI showed significantly decreased urinary
levels of albumin and TGF-b1 in comparison with those treated
with calcium antagonists and b-blockers [43].
We observed relatively higher concentrations of BUN than SCr
in patients with CHF. This is considered to be due to an increased
passive reabsorption of urea associated with enhanced water
Fig. 6. Comparison of PaO2 (A) and hematocrit (Hct), (B) levels among
subgroups with various causes of CHF. The CA subgroup showed
significantly lower PaO2 (F 5 5.058; *P , 0.02) and higher Hct (F 5 3.739;
*P , 0.03) compared to the other subgroups. Abbreviations are: CA,
congenital anomalies; OMI, old myocardial infarction; VD, valvular
disease; CM, cardiomyopathy. The data are mean 1 SD.
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reabsorption in the development of edema, and due to a possible
hyperfiltration mechanism by up-regulated angiotensin II as sup-
ported by increased glomerular size, which preserves glomerular
filtration rate and augments creatinine excretion. The grades of
ML, glomerulomegaly and glomerular mononuclear cell infiltra-
tion did not show significant correlation with any of the clinical
parameters of the level of proteinuria, SCr or BUN. However,
taking into account that these clinical parameters are greatly
influenced by systemic and renal circulatory factors such as
cardiac function, total blood volume, renal plasma flow and renal
vascular resistance, the lack of quantitative correlation with
clinical parameters might not deny the pathological significance of
these mesangiolytic glomerulopathy in patients with severe CHF
exhibiting prerenal azotemia. Mesangiolysis may be a reflection of
acute or subchronic alterations in critically ill condition of CHF or
induced by cardiogenic shock or long-term intensive treatments.
Further investigations on the clinical hallmarks and ultrastruc-
tural analysis of kidney specimens would help in understanding
the pathological process of ML.
In conclusion, these findings indicate that ML associated with
glomerular enlargement is the major glomerular abnormality
characteristic in patients with severe CHF, and that endocapillary
infiltration of mononuclear leukocytes, especially of macrophages,
could play an important role in the progression of both ML and
Fig. 7. The relationship between mesangiolysis
(ML) index (% glomeruli with microaneurysm)
and the mean glomerular size in the cases of
congestive heart failure (CHF). Quantitatively,
the ML index was not significantly correlated
with the mean glomerular size in the CHF
cases (A; R 5 0.367, P 5 0.055). However,
when the ML index was graded from 0 to 2 (B),
there was a strong correlation with the mean
glomerular size (F 5 7.526, P , 0.004). The
grade 2 group (severe, ML index . 90%)
showed significantly larger glomerular size than
the group with grade 0 (normal, ML index ,
48%) or with grade 1 (mild, ML index:
48–90%) (*P , 0.05, each). The data are mean
1SD.
Fig. 8. The mean number of glomerular
mononuclear leukocytes was highly correlated
with the mean glomerular size (r 5 0.528, P <
0.002, A) and with the mesangiolysis (ML)
index (r 5 0.434, P < 0.03, B) in the cases of
congestive heart failure (CHF).
Fig. 9. The relationship of PaO2 (A) and
hematocrit (Hct) (B) with the mean glomerular
size in the cases of congestive heart failure
(CHF). There was an inverse correlation
between PaO2 and the glomerular size (r 5
0.568, P , 0.01), and a positive correlation
between Hct and the size (r 5 0.468, P , 0.02).
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glomerular enlargement. The significant correlation of hypoxemia
with mesangiolytic mesangial degeneration and glomerular en-
largement suggests a causative role for persistent hypoxia in cases
with CHF, as in the development of glomerulomegaly in cyanotic
congenital heart disease.
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